NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDEnzalutamide 40mg Xtandi®
(Tablets) 		Malignant disease and immunosuppression, Anti-androgens, 08.03.04.02
Links found
NICE TA1130: Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancer
NICE TA316: Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen
NICE TA377: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
NICE TA712: Enzalutamide for treating hormone-sensitive metastatic prostate cancer
NICE TA994: Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (TERMINATED APPRAISAL)